Detalhe da pesquisa
1.
Dynamic Prediction of Advanced Colorectal Neoplasia in Inflammatory Bowel Disease.
Clin Gastroenterol Hepatol
; 2024 Feb 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38431223
2.
A Prediction Model for Successful Increase of Adalimumab Dose Intervals in Patients with Crohn's Disease: Secondary Analysis of the Pragmatic Open-Label Randomised Controlled Non-inferiority LADI Trial.
Dig Dis Sci
; 2024 Apr 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38594435
3.
Complete Endoscopic Healing Is Associated With Lower Relapse Risk After Anti-TNF Withdrawal in Inflammatory Bowel Disease.
Clin Gastroenterol Hepatol
; 21(3): 750-760.e4, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36055567
4.
Prognostic Factors for Advanced Colorectal Neoplasia in Inflammatory Bowel Disease: Systematic Review and Meta-analysis.
Gastroenterology
; 160(5): 1584-1598, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33385426
5.
The Efficacy of an Over-the-Counter Multivitamin and Mineral Supplement to Prevent Infections in Patients With Inflammatory Bowel Disease in Remission With Immunomodulators and/or Biological Agents: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
Inflamm Bowel Dis
; 2023 Oct 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37793072
6.
Therapeutic drug monitoring of methotrexate in patients with Crohn's disease.
Aliment Pharmacol Ther
; 58(11-12): 1151-1162, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37767910
7.
Exposure to Thioguanine During 117 Pregnancies in Women With Inflammatory Bowel Disease.
J Crohns Colitis
; 17(5): 738-745, 2023 May 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36521000
8.
Increased versus conventional adalimumab dose interval for patients with Crohn's disease in stable remission (LADI): a pragmatic, open-label, non-inferiority, randomised controlled trial.
Lancet Gastroenterol Hepatol
; 8(4): 343-355, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36736339
9.
Cost-Effectiveness Analysis of Increased Adalimumab Dose Intervals in Crohn's Disease Patients in Stable Remission: The Randomized Controlled LADI Trial.
J Crohns Colitis
; 17(11): 1771-1780, 2023 Nov 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37310877
10.
Risk factors for rectal stump cancer in inflammatory bowel disease.
Dis Colon Rectum
; 55(2): 191-6, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22228163
11.
Patients Prioritize a Low-volume Bowel Preparation in Colitis-associated Colorectal Cancer Surveillance: A Discrete Choice Experiment.
Inflamm Bowel Dis
; 28(7): 1053-1060, 2022 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34487155
12.
Surveillance and management of colorectal dysplasia and cancer in inflammatory bowel disease: Current practice and future perspectives.
Eur J Intern Med
; 93: 35-41, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34481721
13.
Outcome of Reverse Switching From CT-P13 to Originator Infliximab in Patients With Inflammatory Bowel Disease.
Inflamm Bowel Dis
; 27(12): 1954-1962, 2021 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33538298
14.
Clinical Outcomes of Covid-19 in Patients With Inflammatory Bowel Disease: A Nationwide Cohort Study.
J Crohns Colitis
; 15(4): 529-539, 2021 Apr 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33079178
15.
Declining risk of colorectal cancer in inflammatory bowel disease: an updated meta-analysis of population-based cohort studies.
Inflamm Bowel Dis
; 19(4): 789-99, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23448792
16.
Disease severity does not affect the interval between IBD diagnosis and the development of CRC: results from two large, Dutch case series.
J Crohns Colitis
; 6(4): 435-40, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22398065
17.
Easily obtainable clinical features increase the diagnostic accuracy for latent autoimmune diabetes in adults: an evidence-based report.
Prim Care Diabetes
; 2(4): 207-11, 2008 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-18815086